NPCE - NeuroPace Inc
IEX Last Trade
11.19
-0.070 -0.626%
Share volume: 884
Last Updated: Thu 26 Dec 2024 08:19:30 PM CET
Surgical and Medical Instrument Manufacturing :
1.09%
PREVIOUS CLOSE
CHG
CHG%
$11.26
-0.07
-0.62%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-11 | 2022-11-08 | 2023-03-02 | 2023-05-04 | 2023-08-08 | 2023-11-06 | 2024-03-05 | 2024-05-08 | |
Total revenue | 10.200 M | 11.157 M | 12.789 M | 14.472 M | 16.510 M | 16.427 M | 18.012 M | 18.124 M | |
Cost of revenue | 2.734 M | 3.192 M | 3.986 M | 4.100 M | 4.538 M | 4.194 M | 4.467 M | 4.781 M | |
Gross profit | 7.466 M | 7.965 M | 8.803 M | 10.372 M | 11.972 M | 12.233 M | 13.545 M | 13.343 M | |
6.68% | 10.52% | 17.82% | 15.43% | 2.18% | 10.73% | -1.49% | |||
Operating expenses | 18.440 M | 18.164 M | 18.662 M | 18.691 M | 19.826 M | 18.183 M | 18.596 M | 20.888 M | |
Selling general and admin | 12.771 M | 12.553 M | 13.573 M | 13.428 M | 14.483 M | 13.388 M | 13.219 M | 15.104 M | |
Research and development | 5.669 M | 5.611 M | 5.089 M | 5.263 M | 5.343 M | 4.795 M | 5.377 M | 5.784 M | |
Total expenses | 21.174 M | 21.356 M | 22.648 M | 22.791 M | 24.364 M | 22.377 M | 23.063 M | 25.669 M | |
0.86% | 6.05% | 0.63% | 6.90% | -8.16% | 3.07% | 11.30% | |||
Operating income | -10.974 M | -10.199 M | -9.859 M | -8.319 M | -7.854 M | -5.950 M | -5.051 M | -7.545 M | |
Ebit | -10.974 M | -10.199 M | -9.859 M | -8.319 M | -7.854 M | -5.950 M | -5.051 M | -7.545 M | |
Pretax income | -12.690 M | -11.785 M | -11.146 M | -10.375 M | -9.124 M | -7.257 M | -6.200 M | -8.925 M | |
-7.13% | -5.42% | -6.92% | -12.06% | -20.46% | -14.57% | 43.95% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -12.690 M | -11.785 M | -11.146 M | -10.375 M | -9.124 M | -7.257 M | -6.200 M | -8.925 M | |
7.13% | 5.42% | 6.92% | 12.06% | 20.46% | 14.57% | -43.95% | |||
Net income | -12.690 M | -11.785 M | -11.146 M | -10.375 M | -9.124 M | -7.257 M | -6.200 M | -8.925 M | |
7.13% | 5.42% | 6.92% | 12.06% | 20.46% | 14.57% | -43.95% |